Take Solutions Ltd

Take Solutions Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Take Solutions Ltd

₹ 30.4 2.02%
26 May 4:01 p.m.
takesolutions.com BSE: 532890 NSE: TAKE
About

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

Key Points

Business Overview:[1]
Singapore-based TAKE Solutions Pte Limited holds a 52.90% stake in TSL, serving as the holding company. TSL specializes in Life Sciences and Supply Chain Management, providing comprehensive services in clinical development and specific offerings in supply chain. The company is involved in clinical trials, generics support, including bio-availability & bioequivalent studies, regulatory filing, and pharmacovigilance.

Website BSE NSE - BE
  • Market Cap ₹ 447 Cr.
  • Current Price ₹ 30.4
  • High / Low ₹ 50.1 / 8.16
  • Stock P/E 105
  • Book Value ₹ 2.10
  • Dividend Yield 0.00 %
  • ROCE 18.5 %
  • ROE 16.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 14.5 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -41.2% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of -47.0% over last 3 years.
  • Earnings include an other income of Rs.13.3 Cr.
  • Working capital days have increased from -2,718 days to 123 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Research, Analytics & Technology

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
37.54 3.55 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 54.19
26.54 5.50 1.50 1.98 15.76 2.22 0.90 2.89 1.15 0.44 0.30 0.35 55.01
Operating Profit 11.00 -1.95 -1.45 -1.98 -15.76 -2.22 -0.90 -2.89 -1.15 -0.44 -0.30 -0.35 -0.82
OPM % 29.30% -54.93% -2,900.00% -1.51%
-58.85 -2.25 0.41 4.07 -93.70 -0.97 -0.23 51.31 -3.48 -0.29 6.92 1.46 5.18
Interest 3.92 0.64 0.56 0.54 0.54 0.49 0.50 0.73 0.24 0.18 0.17 0.00 0.00
Depreciation 4.30 0.30 0.30 0.11 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Profit before tax -56.07 -5.14 -1.90 1.44 -110.01 -3.69 -1.64 47.68 -4.88 -0.91 6.45 1.11 4.36
Tax % -0.18% 3.50% -18.42% 248.61% 0.55% 1.63% -3.66% 0.00% 0.00% 0.00% 2.48% 0.00% 0.00%
-55.96 -5.32 -1.55 -2.14 -110.61 -3.75 -1.58 47.68 -4.88 -0.91 6.29 1.11 4.36
EPS in Rs -3.78 -0.36 -0.10 -0.14 -7.48 -0.25 -0.11 3.22 -0.33 -0.06 0.43 0.08 0.29
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
730 1,030 1,345 1,587 2,039 2,213 774 655 189 4 0 54
581 817 1,082 1,281 1,655 2,044 847 648 208 24 7 56
Operating Profit 149 213 262 307 384 169 -73 7 -19 -20 -7 -2
OPM % 20% 21% 20% 19% 19% 8% -9% 1% -10% -569% -4%
8 21 13 6 11 26 -211 -677 -56 -92 47 13
Interest 13 15 23 21 25 41 37 29 7 2 2 0
Depreciation 60 74 87 104 154 167 115 80 17 1 0 0
Profit before tax 85 145 165 188 216 -13 -437 -779 -99 -116 37 11
Tax % 6% 14% 11% 15% 17% -15% 3% 0% 2% 3% 0% 1%
80 125 146 160 178 -11 -450 -782 -100 -120 37 11
EPS in Rs 5.71 9.78 10.74 10.85 11.99 -0.84 -30.56 -52.88 -6.78 -8.09 2.53 0.73
Dividend Payout % 17% 10% 9% 15% 8% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -26%
5 Years: -41%
3 Years: -34%
TTM: %
Compounded Profit Growth
10 Years: -27%
5 Years: 15%
3 Years: 27%
TTM: -89%
Stock Price CAGR
10 Years: -16%
5 Years: -15%
3 Years: 21%
1 Year: 226%
Return on Equity
10 Years: -10%
5 Years: -104%
3 Years: -47%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12 12 13 15 15 15 15 15 15 15 15 15
Reserves 512 619 898 1,314 1,504 1,561 1,110 166 94 -24 6 16
209 336 237 323 474 553 514 59 46 37 0 0
189 246 221 189 339 336 187 984 69 60 16 5
Total Liabilities 922 1,214 1,369 1,840 2,331 2,465 1,826 1,223 224 88 36 36
359 543 554 589 1,091 1,234 934 101 73 30 0 0
CWIP 17 3 21 42 41 1 0 3 11 0 0 0
Investments 6 21 10 59 10 18 7 0 0 0 0 0
541 647 785 1,150 1,188 1,213 885 1,119 140 58 36 36
Total Assets 922 1,214 1,369 1,840 2,331 2,465 1,826 1,223 224 88 36 36

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
74 151 56 121 104 211 135 30 20 9 -16 -4
-14 -292 -130 -179 -474 -233 -57 15 -3 -7 22 2
-11 111 56 302 100 21 -84 -55 -36 -12 -3 -1
Net Cash Flow 49 -30 -18 243 -270 -2 -6 -10 -18 -10 3 -3
Free Cash Flow 46 35 -30 39 -23 54 133 -2 -12 2 -16 -4
CFO/OP 52% 76% 26% 44% 30% 156% -212% 704% -114% -43% 217% 208%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 120 107 118 108 94 116 205 45 58 715 1
Inventory Days 0
Days Payable
Cash Conversion Cycle 120 107 118 108 94 116 205 45 58 715 1
Working Capital Days 42 19 90 85 67 80 140 28 -42 -5,559 123
ROCE % 13% 16% 17% 15% 13% 1% -9% -6% -14% -22% 11% 19%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Jun 2023
New Client Logos Added
Number

Log in to view insights

Please log in to see hidden values.

Login
Total Headcount (Group)
Number
Order Book
USD Million
Days Sales Outstanding (DSO) / Receivables Cycle
Days
Revenue Contribution - Life Sciences Vertical
%
Clinical Trial Bed Capacity (Ecron Acunova)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.34% 5.19% 0.00% 0.00%
0.13% 0.00% 0.00% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.56% 0.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00%
46.46% 46.57% 46.59% 46.56% 46.58% 46.58% 46.59% 46.58% 46.65% 94.81% 99.44% 99.73%
No. of Shareholders 82,04581,18379,33681,93880,28878,03377,16375,98875,14174,41070,32464,699

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls